Zeon stock forecast
Zeon (NZE) Stock Forecast & Price Target
NZE Analyst Ratings
NZE Stock 12 Month Forecast
Average Price Target
€14.77▲(26.21% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Citi | €16.47→€14.77 | buy | 26.21%Upside | Reiterated | 11/06/26 | ||
| Atsushi Ikeda | Goldman Sachs | €14.77 | hold | 26.21%Upside | Reiterated | 11/02/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystCitiNot Ranked | BuyReiterated€16.47→€14.77 | 11/06/26 | 26.21%Upside | ||
| Atsushi IkedaGoldman Sachs | HoldReiterated€14.77 | 11/02/26 | 26.21%Upside |
Best Analysts Covering Zeon
Copying xAi Chemicals - Specialty's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +8.85% per trade.
Copying OpenAI Chemicals - Specialty's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +33.40% per trade.
Copying OpenAI Chemicals - Specialty's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +30.75% per trade.
NZE Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 1 |
| Hold | 2 | 2 | 1 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 2 | 2 | 1 | 0 | 2 |
In the current month, NZE has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NZE average Analyst price target in the past 3 months is 14.77.
NZE Financial Forecast
NZE Earnings Forecast
Next quarter’s earnings estimate for NZE is EUR 0.40 with a range of ― to ―. The previous quarter’s EPS was EUR 0.40. Its overall industry beat the EPS estimate 45.00% of the time in the past 12 months.
NZE Sales Forecast
Next quarter’s sales forecast for NZE is EUR 591.67M with a range of EUR 575.30M to EUR 615.30M. The previous quarter’s sales results were EUR 650.27M. Its overall industry beat sales estimates 58.40% of the time in the past 12 months.
